AnastrozoleA Review of its Use in the Management of Postmenopausal Women with Advanced Breast Cancer

被引：0
作者：
Lynda R. Wiseman
Julie C. Adkins
机构：
[1] Adis International Limited,
来源：
Drugs & Aging | 1998年 / 13卷
关键词：
Aromatase Inhibitor; Advanced Breast Cancer; Letrozole; Anastrozole; Megestrol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Anastrozole is a new oral nonsteroidal aromatase inhibitor indicated for the second-line endocrine treatment of postmenopausal women with advanced breast cancer. In postmenopausal women, anastrozole significantly reduces plasma estrogen levels; maximal suppression is achieved at dosages ≥1 mg/day and levels remain suppressed during long term therapy.
引用
收藏
页码：321 / 332
页数：11
相关论文
共 74 条
  • [1] Jaiyesimi IA(1995)Use of tamoxifen for breast cancer: twenty-eight years later J Clin Oncol 13 513-29
  • [2] Buzdar AU(1998)Update on endocrine therapy for breast cancer Clin Cancer Res 4 527-34
  • [3] Decker DA(1994)Current perspectives on aromatase inhibitors in breast cancer J Clin Oncol 12 2460-70
  • [4] Buzdar AU(1994)Metastatic breast cancer BMJ 309 1501-4
  • [5] Hortobagyi G(1996)Biological background to aromatase inhibition Breast 5 196-201
  • [6] Goss PE(1997)Aromatase inhibitors and breast cancer Cancer Treat Rev 23 171-87
  • [7] Gwyn KMEH(1987)4-Hydroxyandrostenedione treatment for postmenopausal patients with advanced breast cancer Steroids 50 245-52
  • [8] Leonard RCF(1983)Aminoglutethimide for the treatment of advanced postmenopausal breast cancer Eur J Cancer Clin Oncol 19 11-7
  • [9] Rodger A(1996)Formestane: a review of its pharmacological properties and clinical efficacy in the treatment of postmenopausal breast cancer Drugs Aging 9 292-306
  • [10] Dixon JM(1994)Arimidex®: a potent and selective fourth-generation aromatase inhibitor Breast Cancer Res Treat 30 103-11
12345678